An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product list 08d06-39, that has a similar us product distributed in the us, list 8d06-31.There is no additional patient information provided due to privacy issues.
|
A review of tickets determined that there is slightly elevated complaint activity for lot 91382li00, but no trends were identified for the complaint issue.The returned sample was tested with lot 89366li00, as the complaint lot 91382li00 was not available for testing, and nonreactive results of 0.06 s/co and 0.1 s/co were obtained.Although there is no reference test method for the syphilis assay, the sample was also tested with mikrogen recomline treponema igm / igg methods and all generated negative results.Sensitivity testing was performed with a retained kit of lot 91382li00 in a sensitivity setup, including additional replicates of a sensitivity panel.Results of this setup did not implicate that the performance of the lot was negatively impacted, as no false nonreactive results were obtained.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect syphilis tp reagent, lot 91382li00.
|